Latest Regulatory Progress News

Atlas Arteria reported a resilient 2025 with 9.3% EBITDA growth and steady toll revenue, while its Board unanimously urged investors to reject IFM’s unsolicited takeover offer, citing undervaluation and onerous conditions.

Nexsen has secured a strategic partnership with GHK Hospital Limited in Hong Kong, marking a significant step in validating and commercialising its rapid point-of-care diagnostics across North Asia.

Aguia Resources has addressed all regulatory queries for its Tres Estradas phosphate mine operating licence, with final approval expected soon. The project remains on track for mid-May operational readiness, while its Pampafos fertiliser offers a significant cost edge amid supply shortages in Southern Brazil.

Arovella Therapeutics has named Dr Nicole Van Der Weerden as acting CEO following Dr Michael Baker’s departure, positioning her to steer the company through the critical phase I trial of its CAR-iNKT therapy ALA-101.

Sky Metals accelerates development of its Tallebung tin-tungsten-silver project with NSW State Significant Development approval process initiated and over 500 drill holes underpinning an updated resource and feasibility study.

Noxopharm is gearing up for a pivotal pre-IND meeting with the US FDA, enlisting global CRO Novotech to sharpen its regulatory approach for SOF-SKN, a drug targeting autoimmune skin diseases.

NeuRizer Ltd advanced its urea project with Reliance Industries payments and environmental submissions, despite ongoing ASX trading suspension and overdue financial reports.

Imricor Medical Systems has secured A$60 million through a placement to fund its US commercial rollout, regulatory approvals, and clinical programs, boosting its cash reserves to nearly A$103 million.

Energy Transition Minerals has released a JORC-compliant Mineral Resource Estimate for its Penouta tin-tantalum-niobium mine in Spain, reinforcing its strategic role in Europe's critical minerals supply chain and setting the stage for a project restart.

Sinowin Lithium, MRG Metals’ JV partner, will fund drilling at Corridor North in Mozambique, extending its investment beyond the 2 billion tonne Corridor Central and South projects targeting 2027 production and a ramp-up to 800,000 tonnes per annum.

RareX Limited has advanced its rare earths ambitions by securing a key mining lease at Cummins Range, appointing a strategic board member, and raising $5 million to fund exploration and development.

Alterity Therapeutics secures FDA backing on key Phase 3 elements for ATH434 in Multiple System Atrophy, bolstered by fresh Phase 2 data showing slowed disease progression and strategic leadership hires.